{"title":"Effectiveness of Plasmapheresis in Aluminum Phosphate Poisoning.","authors":"Shiva Samsam Shariat, Shafeajafar Zoofaghari, Farzad Gheshlaghi","doi":"10.4103/jrpp.JRPP_21_27","DOIUrl":null,"url":null,"abstract":"1. Tawfik HM. Recent advances in management of aluminium phosphide poisoning. QJM Int J Med 2020;113 Suppl 1:hcaa049.002. [doi: https://doi.org/10.1093/ qjmed/hcaa049.002]. 2. Elgazzar FM. Assessment of Intravenous lipid emulsion as an adjuvant therapy in acute aluminum phosphide poisoning: A randomized controlled trial. QJM Int J Med 2020;113 Suppl 1:hcaa049.001. [doi: https://doi.org/100.1093/ qjmed/hcaa049.001]. 3. Gheshlaghi F, Lavasanijou MR, Moghaddam NA, Khazaei M, Behjati M, Farajzadegan Z, et al. N-acetylcysteine, ascorbic acid, and methylene blue for the treatment of aluminium phosphide poisoning: Still beneficial? Toxicol Int 2015;22:40‐4. 4. Dorooshi G, Zoofaghari S, Mood NE, Gheshlaghi F. A newly proposed management protocol for acute aluminum phosphide poisoning. J Res Pharm Pract 2018;7:168-9. 5. Moghadamnia AA. An update on toxicology of aluminum phosphide. Daru 2012;20:25. 6. Tahergorabi Z, Zardast M, Naghizadeh A, Mansouri B, Nakhaei I, Zangouei M. Effect of aluminium phosphide (ALP) gas inhalation exposure on adipose tissue characteristics and histological toxicity in male rats. J Taibah Univ Sci. 2020;14:1317-25. Letter to the Editor","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"57"},"PeriodicalIF":0.8000,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f8/42/JRPP-10-57.PMC8259597.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Research in Pharmacy Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jrpp.JRPP_21_27","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
1. Tawfik HM. Recent advances in management of aluminium phosphide poisoning. QJM Int J Med 2020;113 Suppl 1:hcaa049.002. [doi: https://doi.org/10.1093/ qjmed/hcaa049.002]. 2. Elgazzar FM. Assessment of Intravenous lipid emulsion as an adjuvant therapy in acute aluminum phosphide poisoning: A randomized controlled trial. QJM Int J Med 2020;113 Suppl 1:hcaa049.001. [doi: https://doi.org/100.1093/ qjmed/hcaa049.001]. 3. Gheshlaghi F, Lavasanijou MR, Moghaddam NA, Khazaei M, Behjati M, Farajzadegan Z, et al. N-acetylcysteine, ascorbic acid, and methylene blue for the treatment of aluminium phosphide poisoning: Still beneficial? Toxicol Int 2015;22:40‐4. 4. Dorooshi G, Zoofaghari S, Mood NE, Gheshlaghi F. A newly proposed management protocol for acute aluminum phosphide poisoning. J Res Pharm Pract 2018;7:168-9. 5. Moghadamnia AA. An update on toxicology of aluminum phosphide. Daru 2012;20:25. 6. Tahergorabi Z, Zardast M, Naghizadeh A, Mansouri B, Nakhaei I, Zangouei M. Effect of aluminium phosphide (ALP) gas inhalation exposure on adipose tissue characteristics and histological toxicity in male rats. J Taibah Univ Sci. 2020;14:1317-25. Letter to the Editor
期刊介绍:
The main focus of the journal will be on evidence-based drug-related medical researches (with clinical pharmacists’ intervention or documentation), particularly in the Eastern Mediterranean region. However, a wide range of closely related issues will be also covered. These will include clinical studies in the field of pharmaceutical care, reporting adverse drug reactions and human medical toxicology, pharmaco-epidemiology and toxico-epidemiology (poisoning epidemiology), social aspects of pharmacy practice, pharmacy education and economic evaluations of treatment protocols (e.g. cost-effectiveness studies). Local reports of medication utilization studies at hospital or pharmacy levels will only be considered for peer-review process only if they have a new and useful message for the international pharmacy practice professionals and readers.